Paradigm Biopharmaceuticals Limited

ASX:PAR.AX

0.22 (AUD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 17.82133.55156.33383.92639.67454.79871.03585.206103.92270.93478.8369.9342.4466.0022.5915.0252.9985.2660.125
Short Term Investments 0.04600.04600.0460.2320.0460.7460.7462.6966.500000000
Cash and Short Term Investments 17.86733.55156.37983.92639.72155.0371.08185.953104.66873.6378.8369.9342.4466.0022.5915.0252.9985.2660.125
Net Receivables 5.0837.4276.8070.2656.7197.1568.5083.4983.513.3063.5320.4562.7350.0331.8151.3521.34200
Inventory 0000000000-3.5320-2.7350-1.8150-1.34200
Other Current Assets 1.3040.850.5990.9520.7311.6931.3891.9090.1920.3093.6690.2052.8270.1921.8360.1021.350.0850.713
Total Current Assets 24.25341.82863.78685.14447.1763.87980.97891.359108.37177.24582.50610.5945.2726.2274.4266.4794.3495.3510.838
Non-Current Assets:
Property, Plant & Equipment, Net 0.190.2630.3360.4130.5710.6680.7640.8710.9431.0220.0240.0070.0090.0130.0140.020.0110.0030
Goodwill 0000000000000000000
Intangible Assets 2.9482.9482.9482.9482.9482.9482.9482.9482.9482.9822.9819.9099.9110.0399.9059.8397.9887.7430.356
Goodwill and Intangible Assets 2.9482.9482.9482.9482.9482.9482.9482.9482.9482.9822.9819.9099.9110.0399.9059.8397.9887.7430.356
Long Term Investments 0000000.10300.1030000000000
Tax Assets 000000-0.1030-0.1030000000000
Other Non-Current Assets -0-0-3.284-3.361-3.519-3.6150.1030.1030.103-4.004-3.005-9.916-9.919-0-9.919-9.859-7.998-7.746-0.356
Total Non-Current Assets 3.1373.2113.2843.3613.5193.6153.8153.9213.9934.0043.0059.9169.91910.0529.9199.8597.9987.7460.356
Total Assets 27.3945.03967.0788.50550.68967.49484.79295.281112.36481.24985.51120.51115.19116.27914.34516.33812.34713.0971.194
Liabilities & Equity:
Current Liabilities:
Account Payables 2.8219.98612.16113.6687.08813.3264.9864.3442.7840.692.2790.8681.031.1580.771.4990.990.3840.384
Short Term Debt 0.1220.1130.1050.1020.1480.1440.1350.1310.1250.1170.03700.03700.03700.0370.0370.172
Tax Payables 0000000000000000000
Deferred Revenue 0000000000-0.0370-0.0370-0.0370-0.03700
Other Current Liabilities 0.4170.8230.7760.6810.5950.4910.6720.5850.4560.3530.4250.2840.2970.2040.1860.1340.12700.029
Total Current Liabilities 3.3610.92213.04214.4527.83113.9615.7935.0593.3651.1592.7051.1511.3271.3620.9551.6331.1170.420.585
Non-Current Liabilities:
Long Term Debt 0.1170.1770.2370.2880.4690.4510.6170.6830.7490.814000000000
Deferred Revenue Non-Current 0000000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000000
Other Non-Current Liabilities 0.1070.140.1130.10.0760.1630.1080.0890.068-0000000000
Total Non-Current Liabilities 0.2250.3170.350.3880.5450.6140.7250.7730.8170.814000000000
Total Liabilities 3.58411.2413.39214.8398.37614.5756.5195.8324.1821.9732.7051.1511.3271.3620.9551.6331.1170.420.585
Equity:
Preferred Stock 0000000000000000000
Common Stock 238.113238.113209.834209.55147.195147.069146.989146.511145.865110.551109.46836.42726.94125.80821.05721.05815.07215.0741.577
Retained Earnings -220.73-211.754-163.514-144.323-114.016-101.818-75.228-61.836-41.269-35.305-30.735-19.508-15.107-12.49-8.917-7.46-4.642-3.146-1.717
Accumulated Other Comprehensive Income/Loss 6.4237.447.3588.4399.1337.6686.5124.7743.5854.034.0732.442.3391.61.251.1080.80.7490.749
Other Total Stockholders Equity 000000000000-0.308000000
Total Shareholders Equity 23.80633.79953.67873.66642.31352.9278.27389.449108.18279.27682.80619.35913.86414.91713.3914.70611.2312.6770.609
Total Equity 23.80633.79953.67873.66642.31352.9278.27389.449108.18279.27682.80619.35913.86414.91713.3914.70611.2312.6770.609
Total Liabilities & Shareholders Equity 27.3945.03967.0788.50550.68967.49484.79295.281112.36481.24985.51120.51115.19116.27914.34516.33812.34713.0971.194